PATENT CLAIM ANALYSIS

Application Number: 16357898
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds as inhibitor of WNT signal transduction pathway, as well as a composition comprising the same. Further, the present invention relates to the use of the compounds in the treatment of fibrosis.

Claim (Index 6):
The method of  claim 1 , wherein said pharmaceutical composition further comprises adjuvants, wherein the adjuvants are preserving, stabilizing, wetting or emulsifying agents, solution promoters, salts for regulating the osmotic pressure, or buffers, or a combination thereof.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 99.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15650494', '14772334', '16261353', '15617988', '14772337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8420837119056462
- 35 USC 102 Novelty (BERT): 0.6553242716373265
- Combined Prediction Score: 0.8234077678788143
- Mean Citation Score: 521.541686
- Max Citation Score: 627.08813
- Similarity Product: 622.2198403106909

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test